As an HRHR clinical trial participant, you play a vital role in advancing medical therapies that can improve countless lives – starting with your own. If you meet the criteria for a specific trial, you’ll receive a thorough medical screening that provides valuable information about your health. Throughout the process, you’ll always have access to a physician and care team whose first priority is your comfort and safety.
Currently Enrolling Trials
RSV/COVID-19 Combination Vaccine
Males and females, 50+ years of age
This trial involves 2 vaccines: a COVID-19 vaccine, called Comirnaty, containing Omicron XBB.1.5 and an investigational RSVPreF3 vaccine. These vaccines WILL NOT cause you to acquire RSV or COVID-19. You will either get the vaccines together or separated by one month depending on what group you are randomly assigned to in the trial. The trial is being conducted to determine how the body responds in each group.
Eligibility
- MUST NOT have had a previous RSV vaccine
- MUST NOT have had a COVID-19 vaccine in the last 3 months
- Cannot have a diagnosis of an autoimmune disease
Trial Duration
7 month trial with 3 appointments within the first 60 days of the trial
Compensation
$125 per appointment and $25 per phone call.
Apply to this trial
Endometriosis and/or Uterine Fibroids
Females, 18-50 years of age.
This clinical trial is to evaluate bone mineral density with long-term use of Relugolix combination tablet (Myfembree). This is an oral medication (taken by mouth). Currently, this medication is FDA approved for 2-year use, and this trial will study the medication taken during 4 years, and follow changes in bone mineral density for 1 year after treatment has stopped.
Eligibility
- MUST have a medical diagnosis of endometriosis OR uterine fibroids.
- MUST have pain and heavy menstrual bleeding.
- Cannot have a diagnosis of major depressive disorder, bipolar depression, PTSD, or schizophrenia.
Trial Duration
5 year trial with appointments occurring approximately every 6 months.
Compensation
$125 per appointment and $75 per phone call.
Apply to this trial
Hypercholesterolemia (with Heart Condition)
Males and females, 18 years of age and older
The main purpose of this trial is to evaluate the efficacy (how well the drug works in lowering cholesterol) and safety of Merck drug, MK-0616 in individuals with heterozygous familial high cholesterol.
Eligibility
- Must currently take at least 1 high cholesterol medication
- Must have elevated cholesterol numbers
- Must have had a heart attack or stroke
Trial Duration
The trial will last up to 15 months involving 9 visits to our office
Compensation
Participants compensation varies per appointment ($50-$125)
Apply to this trial
Hypercholesterolemia
Males and females, 18+ years of age
Health Research of Hampton Roads is looking for males and females 18 years of age and older to participate in a high cholesterol clinical trial. This trial is to evaluate the efficacy (how well the drug works in lowering cholesterol) and safety of Merck drug, MK-0616 in individuals at high cardiovascular risk.
Eligibility
- Must be taking a cholesterol medication
- Must have elevated cholesterol numbers
- Must have had a heart attack OR stroke OR have type 2 diabetes & high blood pressure
Trial Duration
This trial will be about 4.5 years long (potentially a maximum of 6 years), and you will have up to 18 visits & 12 phone calls
Compensation
$100 per completed appointment | $25 per completed phone call
Apply to this trial
COVID-19 Booster (12+ years) -Scheduling Soon!
Males and females, 12+ years of age
We are looking for males and females aged 12 years and older to participate in a clinical trial for a Moderna COVID-19 vaccine booster. There is NO PLACEBO in this trial. Everyone receives the vaccine.
Eligibility
- Cannot have had a COVID vaccine in the last 90 days
- Cannot have had 6 or more previous COVID vaccines
- Cannot have an autoimmune disease
Trial Duration
This trial will involve 1 year, 6 appointments & 4 phone calls
Compensation
$125 per completed appointment, $50 per completed phone call, additional compensation available for completed diary entries
Apply to this trial
Weight Loss Trial (18-75 years) – On a waiting list
Males and females, 18-75 years of age
The trial is being conducted to compare how well different doses of the medicine NNC0519-0130 help people with excess body weight lose weight. You will self-inject the medication once a week during the 9 month treatment period. You will be trained by our staff on how to use the pen injector in the thigh, stomach, or upper arm. You will receive 1-2 injections per week depending on what group you are assigned to.
Eligibility
- Cannot have type 1 or type 2 diabetes
- Cannot have had previous weight loss surgery
- Cannot be diagnosed or taking medication for heartburn/GERD
- Cannot have major depressive disorder, schizophrenia, or bipolar depression
Trial Duration
There will be a total of 12 appointments to our office and 12 phone calls over 40 weeks
Compensation
$75 per completed appointment | $35 per completed phone call
Apply to this trialWant to know more about upcoming trials?
We're regularly conducting trials for a variety of health conditions. If you'd like to be informed about future opportunities to participate, join our no-obligation mailing list.
